Related Experiment Video
Updated: Jun 6, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Summary statement: utility of molecular marker testing in thyroid cancer
Linwah Yip1, Electron Kebebew, Mira Milas
1Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. yipl@upmc.edu
Surgery
|December 8, 2010
Summary
Molecular markers are revolutionizing thyroid cancer care. New markers promise to enhance the diagnostic accuracy of fine needle aspiration biopsy and improve prognostic predictions for patients.
Area of Science:
- Endocrinology
- Oncology
- Molecular Diagnostics
Background:
- Molecular markers are increasingly vital in understanding and managing thyroid cancer.
- Advances in molecular marker research offer potential improvements in clinical decision-making.
Purpose of the Study:
- To explore the evolving role of molecular markers in thyroid cancer diagnosis, prognosis, and surveillance.
- To highlight recent advancements and their potential clinical applications.
Main Methods:
- Review of recent investigative focus on promising new molecular markers.
- Discussion of findings presented at the American Association for Endocrine Surgeons 2010 Annual Meeting symposium.
Main Results:
- Emerging molecular markers show potential to improve the diagnostic accuracy of fine needle aspiration biopsy (FNAB).
- New markers may offer more precise prognostic information both before and after surgical intervention.
Conclusions:
- Molecular marker testing is poised to significantly enhance the clinical utility of FNAB in thyroid cancer.
- Continued research into molecular markers will likely lead to more accurate patient management and improved outcomes.
